236 related articles for article (PubMed ID: 33611822)
1. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging.
Levine MD; Brown J; Crane EK; Tait DL; Naumann RW
J Minim Invasive Gynecol; 2021 Apr; 28(4):824-828. PubMed ID: 32730990
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Conization and Risk of Recurrence in Patients Undergoing Laparoscopic Radical Hysterectomy for Early Stage Cervical Cancer: A Multicenter Study.
Casarin J; Bogani G; Papadia A; Ditto A; Pinelli C; Garzon S; Donadello N; Laganà AS; Cromi A; Mueller M; Raspagliesi F; Ghezzi F
J Minim Invasive Gynecol; 2021 Jan; 28(1):117-123. PubMed ID: 32320800
[TBL] [Abstract][Full Text] [Related]
5. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
6. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
[TBL] [Abstract][Full Text] [Related]
7. Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer.
Ding Y; Zhang X; Qiu J; Li C; Hua K
Arch Gynecol Obstet; 2023 Jun; 307(6):1901-1909. PubMed ID: 36329212
[TBL] [Abstract][Full Text] [Related]
8. Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review.
Lucchini SM; Ferreyra HD; Landeros J; Esteban A; Donetch G; Goldsman MG; Borla HF; Heredia F
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():163-168. PubMed ID: 34673464
[TBL] [Abstract][Full Text] [Related]
9. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
10. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
11. Validation of the 2018 FIGO Classification for Cervical Cancer: Lymphovascular Space Invasion Should Be Considered in IB1 Stage.
Balaya V; Guani B; Magaud L; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F; On Behalf Of The Senticol Group
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260758
[TBL] [Abstract][Full Text] [Related]
12. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
14. Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?
Vetter MH; Smrz S; Gehrig PA; Peng K; Matsuo K; Davidson BA; Cisa MP; Lees BF; Brunette LL; Tucker K; Stuart Staley A; Gotlieb WH; Holloway RW; Essel KG; Holman LL; Goldfeld E; Olawaiye A; Rose S; Uppal S; Bixel K
Gynecol Oncol; 2020 Nov; 159(2):354-358. PubMed ID: 32888724
[TBL] [Abstract][Full Text] [Related]
15. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
Sert BM; Kristensen GB; Kleppe A; Dørum A
Gynecol Oncol; 2021 Aug; 162(2):284-291. PubMed ID: 34083029
[TBL] [Abstract][Full Text] [Related]
17. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
18. Identifying selection criteria for non-radical hysterectomy in FIGO stage IB cervical cancer.
Kasamatsu T; Ishikawa M; Murakami N; Okada S; Ikeda SI; Kato T; Itami J
J Obstet Gynaecol Res; 2019 Apr; 45(4):882-891. PubMed ID: 30672089
[TBL] [Abstract][Full Text] [Related]
19. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
